Investor Presentaiton
World Class Facilities
Taiwan
■API Plant
.
5 of 16 production lines equipped with high
potency capabilities for cytotoxic/steroid
Provides comprehensive contract research &
manufacturing services for brand drug
companies
■Injectable Plant
•
Vial and cartridge production lines for
oncological and peptide products
To meet US, EU, Japan GMP standards with
adopting state-of-the-art isolator technology
and single use technology for product
contact path
GB-3806A
China
■API Plant
•
•
3 of 7 production lines equipped with high
potency capabilities for cytotoxic
US FDA approved cGMP facility for
intermediates & high potency API
Full scope capabilities in the development
and production of APIs on small to large
scales for generic & CRAM markets
Strategic partnerships with China clients with
downstream formulations and mutually.
target for global and China markets
Swan
7
神隆弱(常)有限公司
ScinoPharmView entire presentation